Phase I Trial of Antigen-Specific Gene Therapy Using a Recombinant Vaccinia Virus Encoding MUC-1 and IL-2 in MUC-1-Positive Patients With Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Phase I Trial of Antigen-Specific Gene Therapy Using a Recombinant Vaccinia Virus Encoding MUC-1 and IL-2 in MUC-1-Positive Patients With Advanced Prostate Cancer

Published:2004 Issue:3 Volume:27 Page:240-253
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Pantuck Allan J.,van Ophoven Arndt,Gitlitz Barbara J.,Tso Cho-Lea,Acres Bruce,Squiban Patrick,Ross Michael E.,Belldegrun Arie S.,Figlin Robert A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference34 articles.

1. Long-term trends in cancer mortality in the United States, 1930-1998

2. T-Cell Recognition of Human Melanoma Antigens

3. Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer

4. Presentation of MUC1 Tumor Antigen by Class I MHC and CTL Function Correlate with the Glycosylation State of the Protein Taken Up by Dendritic Cells

5. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention;2024-05-10

2. Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts;Cytokine;2023-09

3. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

4. Armored modified vaccinia Ankara in cancer immunotherapy;Viral Vectors in Cancer Immunotherapy;2023

5. Considering the potential for gene-based therapy in prostate cancer;Nature Reviews Urology;2021-02-26